CSL Ltd (CSL)

308.86
+1.14(+0.37%)
  • Volume:
    384,523
  • Bid/Ask:
    308.85/308.86
  • Day's Range:
    306.18 - 311.47

CSL Overview

Prev. Close
307.72
Day's Range
306.18-311.47
Revenue
9.44B
Open
306.18
52 wk Range
254.3-314.28
EPS
4.4
Volume
384,523
Market Cap
148.66B
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
671,628
P/E Ratio
45.06
Beta
0.188
1-Year Change
13.73%
Shares Outstanding
482,372,083
Next Earnings Date
-
What is your sentiment on CSL?
or
Market is currently closed. Voting is open during market hours.

CSL Ltd Company Profile

CSL Ltd Company Profile

Employees
30000
Market
Australia

CSL Limited (CSL) is an Australia-based biotechnology company. The Company’s areas of focus and exploration include rare and serious diseases, influenza vaccines, plasma collection, and therapies for iron deficiency and nephrology. The Company’s segments include CSL Behring, CSL Seqirus, and CSL Vifor. The CSL Behring segment manufactures, markets, and distributes plasma therapies (plasma products and recombinants). CSL Seqirus segment manufactures, markets, and distributes primarily influenza-related products and provides pandemic services to governments. The Company’s CSL Vifor segment manufactures, markets, and distributes products in the therapeutic areas of iron deficiency, dialysis and nephrology and rare diseases. The Company’s geographical areas of operation include Australia, the United States of America, Germany, the United Kingdom, Switzerland, and China. CSL’s products include HIZENTRA, PRIVIGEN, IDELVION, HAEMATE, KCENTRA, HAEGARDA, ZEMAIRA/RESPREEZA, FLUAD and FLUCELVAX.

Read More

Analyst Price Target

Average229.38 (-25.73% Downside)
High245.37
Low172.97
Price308.86
No. of Analysts18
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Analysts Consensus

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesSellSellSellBuyStrong Buy
Technical IndicatorsBuyStrong SellSellStrong BuyStrong Buy
SummaryNeutralStrong SellSellStrong BuyStrong Buy
  • At last....
    0